BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35944359)

  • 21. AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion.
    Ma Y; Xia Z; Ye C; Lu C; Zhou S; Pan J; Liu C; Zhang J; Liu T; Hu T; Xie L; Wu G; Zhao Y
    Aging (Albany NY); 2019 Jun; 11(12):3969-3992. PubMed ID: 31219799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
    Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
    Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
    Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
    Yuan L; Zhang H; Liu J; Rubin JB; Cho YJ; Shu HK; Schniederjan M; MacDonald TJ
    Mol Cancer; 2013 Mar; 12():18. PubMed ID: 23497290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis.
    Li CM; Gocheva V; Oudin MJ; Bhutkar A; Wang SY; Date SR; Ng SR; Whittaker CA; Bronson RT; Snyder EL; Gertler FB; Jacks T
    Genes Dev; 2015 Sep; 29(17):1850-62. PubMed ID: 26341558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
    Gros SJ; Kurschat N; Drenckhan A; Dohrmann T; Forberich E; Effenberger K; Reichelt U; Hoffman RM; Pantel K; Kaifi JT; Izbicki JR
    PLoS One; 2012; 7(10):e47287. PubMed ID: 23082154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-146a suppresses the expression of CXCR4 and alters survival, proliferation and migration rate in colorectal cancer cells.
    Afshar-Khamseh R; Javeri A; Taha MF
    Tissue Cell; 2021 Dec; 73():101654. PubMed ID: 34601384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.
    Wang R; Shi Y; Chen L; Jiang Y; Mao C; Yan B; Liu S; Shan B; Tao Y; Wang X
    Sci Rep; 2015 Dec; 5():17826. PubMed ID: 26658322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin promotes bone metastasis of breast cancer by activating the SDF-1/CXCR4 axis.
    Duan L; Lu Y; Xie W; Nong L; Jia Y; Tan A; Liu Y
    Aging (Albany NY); 2020 Aug; 12(16):16172-16182. PubMed ID: 32836215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long noncoding RNA Falcor regulates Foxa2 expression to maintain lung epithelial homeostasis and promote regeneration.
    Swarr DT; Herriges M; Li S; Morley M; Fernandes S; Sridharan A; Zhou S; Garcia BA; Stewart K; Morrisey EE
    Genes Dev; 2019 Jun; 33(11-12):656-668. PubMed ID: 30923168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Down-expression of FOXA2 in gastric adenocarcinoma].
    Zhang Z; Sun J; Bai Z; Li H; He S; Chen R; Che X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):672-6. PubMed ID: 25940296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of FOXA2 decreases E-cadherin expression and is associated with lymph node metastasis in oral cancer.
    Bow YD; Wang YY; Chen YK; Su CW; Hsu CW; Xiao LY; Yuan SS; Li RN
    Oral Dis; 2020 May; 26(4):756-765. PubMed ID: 31957176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing.
    Basseres DS; D'Alò F; Yeap BY; Löwenberg EC; Gonzalez DA; Yasuda H; Dayaram T; Kocher ON; Godleski JJ; Richards WG; Meyerson M; Kobayashi S; Tenen DG; Halmos B; Costa DB
    Lung Cancer; 2012 Jul; 77(1):31-7. PubMed ID: 22341411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
    Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
    J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma.
    Yang X; Lu Q; Xu Y; Liu C; Sun Q
    Pathol Res Pract; 2020 Jan; 216(1):152787. PubMed ID: 31859114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives.
    Łukaszewicz-Zając M; Mroczko B; Szmitkowski M
    Tumour Biol; 2015 Aug; 36(8):5707-14. PubMed ID: 26130416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression.
    Liu M; Lee DF; Chen CT; Yen CJ; Li LY; Lee HJ; Chang CJ; Chang WC; Hsu JM; Kuo HP; Xia W; Wei Y; Chiu PC; Chou CK; Du Y; Dhar D; Karin M; Chen CH; Hung MC
    Mol Cell; 2012 Jan; 45(2):171-84. PubMed ID: 22196886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
    Uygur B; Wu WS
    Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.